Compositional abnormalities of low density lipoprotein in Type 2 diabetes: an explanation for increased atherogenicity?

被引：0
|
作者：
Phillips, CM
Owens, D
Collins, P
Tomkin, GH
机构：
[1] Royal Coll Surgeons Ireland, Dept Biochem, Dublin 2, Ireland
[2] Univ Dublin Trinity Coll, Dept Endocrinol & Diabet, Dublin 2, Ireland
[3] Adelaide & Meath Hosp, Dublin, Ireland
来源：
DIABETOLOGIA | 2002年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1203
引用
收藏
页码：A387 / A387
页数：1
相关论文
共 50 条
  • [1] Increased atherogenicity of low-density lipoprotein in heavy proteinuria
    Deighan, CJ
    Caslake, MJ
    McConnell, M
    Boulton-Jones, JM
    Packard, CJ
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (05) : 1183 - 1188
  • [2] Increased transvascular low density lipoprotein transport in patients with Type 2 diabetes mellitus
    Feldt-Rasmussen, B
    Kornerup, K
    Nordestgaard, BG
    Borch-Johnsen, K
    Jensen, KS
    Jensen, JS
    DIABETOLOGIA, 2002, 45 : A41 - A41
  • [3] Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol
    Fonseca, Liliana
    Paredes, Silvia
    Ramos, Helena
    Oliveira, Jose Carlos
    Palma, Isabel
    LIPIDS IN HEALTH AND DISEASE, 2020, 19 (01)
  • [4] Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol
    Liliana Fonseca
    Sílvia Paredes
    Helena Ramos
    José Carlos Oliveira
    Isabel Palma
    Lipids in Health and Disease, 19
  • [5] ATHEROGENICITY OF AUTOANTIBODIES AGAINST LOW-DENSITY-LIPOPROTEIN
    OREKHOV, AN
    TERTOV, VV
    AGENTS AND ACTIONS, 1991, 32 (1-2): : 128 - 129
  • [6] Associations of low density lipoprotein particle composition with atherogenicity
    Lada, AT
    Rudel, LL
    CURRENT OPINION IN LIPIDOLOGY, 2004, 15 (01) : 19 - 24
  • [7] Abnormalities in lipoprotein kinetics in Type 2 diabetes
    Verges, Bruno
    CLINICAL LIPIDOLOGY, 2010, 5 (02) : 277 - 289
  • [8] Lipoprotein compositional abnormalities in type I diabetes: Effect of improved glycaemic control
    Perez, A
    Caixas, A
    Carreras, G
    Mauricio, D
    Pou, JM
    Serrat, J
    GomezGerique, J
    deLeiva, A
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1997, 36 (02) : 83 - 90
  • [9] REDUCTION OF LOW-DENSITY LIPOPROTEIN ATHEROGENICITY BY ITS RESIALYLATION
    Comi, Laura
    Giglione, Claudia
    Tolaj, Fationa
    Da Dalt, Lorenzo
    Magni, Paolo
    ATHEROSCLEROSIS, 2024, 395
  • [10] REDUCTION OF LOW-DENSITY LIPOPROTEIN ATHEROGENICITY BY ITS RESIALYLATION
    Surkova, Raisa
    Kashirskikh, Dmitry
    Sobenin, Igor
    Melnichenko, Alexandra
    Orekhov, Alexander N.
    ATHEROSCLEROSIS, 2024, 395
12345